Analysis of Immune and High‐risk Biomarkers in Patients with Relapsed or Refractory Mantle Cell Lymphoma Treated with Glofitamab Monotherapy
Hematological Oncology（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined